This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jul;198(1):175.

doi: 10.1016/j.juro.2017.01.099. Epub 2017 Mar 27.

Editorial Comment

Steven J Weissbart¹

Affiliations

PMID: 28359019
DOI: 10.1016/j.juro.2017.01.099

Comment

Editorial Comment

Steven J Weissbart. J Urol. 2017 Jul.

. 2017 Jul;198(1):175.

doi: 10.1016/j.juro.2017.01.099. Epub 2017 Mar 27.

Author

Steven J Weissbart¹

Affiliation

¹ Department of Urology, Stony Brook University School of Medicine, Stony Brook, New York.

PMID: 28359019
DOI: 10.1016/j.juro.2017.01.099

No abstract available

PubMed Disclaimer

Comment on

The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin Naïve Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double-Blind Phase 3b Trial.
Herschorn S, Kohan A, Aliotta P, McCammon K, Sriram R, Abrams S, Lam W, Everaert K. Herschorn S, et al. J Urol. 2017 Jul;198(1):167-175. doi: 10.1016/j.juro.2017.01.069. Epub 2017 Feb 1. J Urol. 2017. PMID: 28161352 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information